IMRX
Price
$1.56
Change
+$0.08 (+5.41%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
52.18M
74 days until earnings call
INSM
Price
$67.53
Change
+$1.51 (+2.29%)
Updated
May 23 closing price
Capitalization
12.05B
68 days until earnings call
Interact to see
Advertisement

IMRX vs INSM

Header iconIMRX vs INSM Comparison
Open Charts IMRX vs INSMBanner chart's image
Immuneering
Price$1.56
Change+$0.08 (+5.41%)
Volume$40.24K
Capitalization52.18M
Insmed
Price$67.53
Change+$1.51 (+2.29%)
Volume$1.55M
Capitalization12.05B
IMRX vs INSM Comparison Chart
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. INSM commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and INSM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (IMRX: $1.45 vs. INSM: $66.16)
Brand notoriety: IMRX and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 61% vs. INSM: 112%
Market capitalization -- IMRX: $52.18M vs. INSM: $12.05B
IMRX [@Biotechnology] is valued at $52.18M. INSM’s [@Biotechnology] market capitalization is $12.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 1 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while INSM’s TA Score has 5 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 4 bearish.
  • INSM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, INSM is a better buy in the short-term than IMRX.

Price Growth

IMRX (@Biotechnology) experienced а +12.84% price change this week, while INSM (@Biotechnology) price change was -1.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

IMRX is expected to report earnings on Aug 06, 2025.

INSM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($12.1B) has a higher market cap than IMRX($52.2M). INSM YTD gains are higher at: -4.171 vs. IMRX (-34.091). IMRX has higher annual earnings (EBITDA): -63.69M vs. INSM (-818.79M). INSM has more cash in the bank: 1.43B vs. IMRX (36.1M). IMRX has less debt than INSM: IMRX (4.16M) vs INSM (1.15B). INSM has higher revenues than IMRX: INSM (364M) vs IMRX (0).
IMRXINSMIMRX / INSM
Capitalization52.2M12.1B0%
EBITDA-63.69M-818.79M8%
Gain YTD-34.091-4.171817%
P/E RatioN/AN/A-
Revenue0364M-
Total Cash36.1M1.43B3%
Total Debt4.16M1.15B0%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXINSM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 9 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 11 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-2.03%
NUVL - IMRX
43%
Loosely correlated
-0.58%
SRRK - IMRX
31%
Poorly correlated
-0.85%
ENTBF - IMRX
31%
Poorly correlated
N/A
INSM - IMRX
30%
Poorly correlated
+0.21%
DNA - IMRX
29%
Poorly correlated
-7.43%
More

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with NOXOF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then NOXOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.21%
NOXOF - INSM
88%
Closely correlated
N/A
THAR - INSM
76%
Closely correlated
+1.48%
NWPHF - INSM
49%
Loosely correlated
N/A
AGIO - INSM
45%
Loosely correlated
-1.73%
RARE - INSM
38%
Loosely correlated
+0.28%
More